Home / MAN2C1 Knockout Cell Lines

MAN2C1 Knockout Cell Lines

Gene: MAN2C1

Official Full Name: mannosidase alpha class 2C member 1provided by HGNC

Gene Summary: Predicted to enable alpha-mannosidase activity. Predicted to be involved in oligosaccharide catabolic process. Located in nucleoplasm. Implicated in congenital disorder of deglycosylation 2. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO36728 MAN2C1 Knockout cell line (HeLa) Human MAN2C1 1:3~1:6 Negative Online Inquiry
KO36729 MAN2C1 Knockout cell line (HCT 116) Human MAN2C1 1:2~1:4 Negative Online Inquiry
KO36730 MAN2C1 Knockout cell line (HEK293) Human MAN2C1 1:3~1:6 Negative Online Inquiry
KO36731 MAN2C1 Knockout cell line (A549) Human MAN2C1 1:3~1:4 Negative Online Inquiry

Background

MAN2C1 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the MAN2C1 gene, which encodes the enzyme α-mannosidase II. This deletion generates a unique model for studying the impacts of glycoprotein processing and relevant metabolic pathways in various biological contexts. The absence of the MAN2C1 gene leads to alterations in glycan structures, providing researchers with a vital tool to understand the implications of glycosylation abnormalities in diseases such as cancer and congenital disorders.

Key functionalities of these knockout cell lines are rooted in their profound ability to mimic the pathophysiological processes resulting from disrupted glycosylation. By enabling the assessment of cellular responses, protein functions, and the biological activity of glycoproteins, the MAN2C1 knockout model provides insight into the role of glycosylation in cell signaling and immune response. The cell lines can be utilized in high-throughput screening for drug discovery, as well as in the evaluation of novel therapeutic strategies aimed at correcting glycosylation defects.

The scientific importance of MAN2C1 Gene Knockout Cell Lines extends into diverse research and clinical applications. These cell lines serve as critical platforms for elucidating the mechanisms driving glycosylation-related diseases and have the potential to aid in the development of targeted therapies. Their relevance stretches across the fields of oncology, immunology, and biochemistry, making them indispensable in advancing our understanding of glycomic roles in human health.

An undeniable advantage of using MAN2C1 knockout cell lines is their specificity and reliability in modeling glycosylation errors, differentiating them from conventional cell lines that may not accurately reflect these alterations. Moreover, these knockout cells facilitate reproducible results in experiments, enhancing data integrity and reliability for researchers.

Ultimately, the value of MAN2C1 Gene Knockout Cell Lines lies in their ability to bridge genetic modifications with biochemical investigations. Researchers and clinicians can leverage these tools for groundbreaking insights into cellular mechanisms and therapeutic innovations. Our company prides itself on offering high-quality, rigorously validated products that support accelerated research in molecular and cellular biology, underpinned by our commitment to scientific excellence and innovation.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.